Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status

Daphne Y S Vogel1, Elly J F Vereyken, Judith E Glim

  • 1Department of Molecular Cell Biology and Immunology, VU University Medical Center, Van der Boechhorststraat 7, BT Amsterdam, 1081, The Netherlands.

Abstract

Insights

Macrophages in multiple sclerosis (MS) lesions are predominantly activated (M1 type), but many also show intermediate activation. This suggests a complex role for these immune cells in MS pathology, influencing disease progression and potential therapeutic targets.

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Pathology

Background:

  • Macrophages exhibit dual roles in multiple sclerosis (MS) pathology, with potential for neuroprotection or tissue damage.
  • Macrophage activation states, classically activated (M1) and alternatively activated (M2), dictate their functional outcomes.
  • Understanding macrophage activation in MS is crucial for deciphering disease mechanisms.

Purpose of the Study:

  • To investigate the activation status of macrophages and microglia within multiple sclerosis (MS) lesions.
  • To identify reliable markers for distinguishing M1 and M2 macrophage phenotypes in human samples.
  • To characterize the spectrum of macrophage activation in different MS pathological contexts.

Main Methods:

  • Flow cytometry was used to analyze the expression of M1 and M2 markers on human monocyte-derived macrophages.
  • CD40 and mannose receptor (MR) were identified as key distinguishing markers for M1 and M2 macrophages, respectively.
  • The expression of M1/M2 markers was assessed in macrophages/microglia from MS lesions, normal-appearing white matter, and healthy controls.

Main Results:

  • M1 markers (CD40, CD86, CD64, CD32) were highly expressed on microglia in normal-appearing white matter and in active MS lesions.
  • M2 markers (MR, CD163) were found on myelin-laden and perivascular macrophages within active MS lesions.
  • Approximately 70% of CD40-positive macrophages in MS lesions co-expressed MR, indicating an intermediate activation status.

Conclusions:

  • Macrophages in active MS lesions primarily exhibit M1 characteristics.
  • A significant subset of macrophages within MS lesions displays an intermediate activation phenotype.
  • These findings highlight the complexity of macrophage polarization in MS and its implications for disease pathogenesis.